You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
This Podcast features an interview with Ann-Kathrin Eisfeld and Albert de la Chapelle, authors of a Research Article that appears in the 15 April 2014 issue of Science Signaling, about a microRNA (miR) that drives acute myeloid leukemia. Acute myeloid leukemia (AML) is a rare form of cancer, but it is the most common form of leukemia that affects adults and has a high mortality rate. The gene encoding miR-3151 is nested within an intron of the BAALC gene. The BAALC/miR-3151 locus has been associated with poor prognosis in a subset of AML patients, but it has been unclear how each gene contributes to cancer. Eisfeld et al. determined that miR-3151 was the primary oncogenic driver at this locus and promoted oncogensis by repressing p53-mediated apoptosis.
